platinum has been researched along with Adrenocortical Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedrose, S; Berruti, A; Dekkers, OM; Fassnacht, M; Habra, MA; Kimpel, O; Kroiss, M; Mai, K; Megerle, F; Terzolo, M | 1 |
| Lage, H; Liedert, B; Materna, V; Thomale, J | 1 |
2 other study(ies) available for platinum and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Case-Control Studies; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Neoplasm Staging; Platinum; Propensity Score; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2021 |
Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.
Topics: Adrenocortical Carcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Base Sequence; Caspase 3; Caspases; Cisplatin; Cross-Linking Reagents; DNA Adducts; DNA Repair; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Kinetics; Melanoma; Molecular Sequence Data; Ovarian Neoplasms; Platinum; RNA, Catalytic; Skin Neoplasms; Tumor Cells, Cultured | 2005 |